Fecal excretion of deoxyribonucleic acid in long-term follow-up of patients with inactive ulcerative colitis

Inflammatory Bowel Diseases

Volumn 13, Issue 4, 2007, Pages 386-390

  Casellas, Francesc ^a   Borruel, Natalia ^a   Antolín, Maria ^a   Varela, Encarnación ^a   Torrejón, Antonio ^b   Armadans, Lluis ^a   Guarner, Francisco ^a   Malagelada, Juan R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE

Author keywords

Disease activity; Fecal marker; Human DNA; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CALPROTECTIN; DNA; MESALAZINE;

ADULT; ARTICLE; CONTROLLED STUDY; DESQUAMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FECES; FEMALE; FOLLOW UP; HUMAN; INFLAMMATORY CELL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; ULCERATIVE COLITIS;

ADULT; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; POLYMERASE CHAIN REACTION; RECURRENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34247585482     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20042     Document Type: Article

References (15)

1. Gomes P, Boulay C, Smith CL, Holdstock G. Relationship between activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986;27:92-95.
2. Geboes K, Riddell R, Öst A, Jensfelt B, Persson T, Löfberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47:404-409.
3. Casellas F, Papo M, Guarner F, Antolín M, Armengol JR, Malagelada JR. Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis. Clin Sci. 1994;87:453-458.
4. Casellas F, Papo M, Guarner F, et al. Intracolonic release in vivo of interleukin-1β in chronic ulcerative colitis. Clin Sci. 1995;89:521-526.
5. Tribble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;19: 15-22.
6. Shanahan F. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics and ecotherapeutics. Gastroenterology 2001;120:622-635.
7. Casellas F, Antolín M, Varela E, et al. Fecal excretion of human deoxyribonucleic acid as an index of inflammatory activity in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2:683-689.
8. Walmsley RS, Ayres RCS, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut .1998;43:29-32.
9. Liu TC, Chang JG, Lin CP, et al. Detection of beta-globin gene from single hairs. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih. 1990;6:181-185.
10. Roseth AG, Schmidt TN, Fagerhol MK. Correlation between faecel excretion of indium 111-labeled granulocytes and calprotectin, a granulocyte marker protein in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34:50-54.
11. Langhorst J, Elsenbruch S, Mueller T, et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis. 2005;11:1085-1091.
12. Silberer H, Kuppers B, Mickisch O, et al. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab. 2005;51:117-126.
13. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000;119; 15-22.
14. Costa F, Mumolo MG, Ceccarelli L, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative collitis than in Crohn's disease. Gut. 2005;54:364-368.
15. Pardi DS, Sandborn WJ. Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers? Gut. 2005;54:321-322.